Literature DB >> 8208340

Characterization of the microglial response in murine scrapie.

A E Williams1, L J Lawson, V H Perry, H Fraser.   

Abstract

The nature of the glial and inflammatory cell responses to infection in scrapie-affected brains was studied in terminally-affected mice of five scrapie models. There were marked astrocytic and microglial responses. Microglia showed increased staining of the surface antigens F4/80, leucocyte-common antigen, type 3 complement receptor, and elevated endocytotic and lysosomal activity. In all models, the astrocytic and microglial responses were largely restricted to anatomical regions of the brain showing vacuolation and/or plaque formation and pathological accumulations of PrP. Expression of MHC Class II was patchy and present on microglia in the neuropil of areas with the most intense microglial activation and on occasional perivascular macrophages. This microglial response may represent a modified form of inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8208340     DOI: 10.1111/j.1365-2990.1994.tb00956.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  37 in total

1.  Identification of upregulated genes in scrapie-infected brain tissue.

Authors:  C Riemer; I Queck; D Simon; R Kurth; M Baier
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease.

Authors:  Kc Biju; Qing Zhou; Guiming Li; Syed Z Imam; James L Roberts; William W Morgan; Robert A Clark; Senlin Li
Journal:  Mol Ther       Date:  2010-06-08       Impact factor: 11.454

3.  IL-1 family members as candidate genes modulating scrapie susceptibility in sheep: localization, partial characterization, and expression.

Authors:  Ane Marcos-Carcavilla; Jorge H Calvo; Carmen González; Katayoun Moazami-Goudarzi; Pascal Laurent; Maud Bertaud; Hélène Hayes; Anne E Beattie; Carmen Serrano; Jaber Lyahyai; Inmaculada Martín-Burriel; Estefânia Alves; Pilar Zaragoza; Juan J Badiola; Magdalena Serrano
Journal:  Mamm Genome       Date:  2007-01-22       Impact factor: 2.957

Review 4.  Microglia in prion diseases.

Authors:  Adriano Aguzzi; Caihong Zhu
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

5.  Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins.

Authors:  C K Combs; D E Johnson; S B Cannady; T M Lehman; G E Landreth
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

6.  Statins are ineffective at reducing neuroinflammation or prolonging survival in scrapie-infected mice.

Authors:  James A Carroll; Brent Race; Katie Phillips; James F Striebel; Bruce Chesebro
Journal:  J Gen Virol       Date:  2017-07-31       Impact factor: 3.891

Review 7.  Antigen-presenting cell diversity for T cell reactivation in central nervous system autoimmunity.

Authors:  Ari Waisman; Lisa Johann
Journal:  J Mol Med (Berl)       Date:  2018-11-01       Impact factor: 4.599

8.  Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells.

Authors:  Valentina Villa; Stefano Thellung; Alessandro Corsaro; Federica Novelli; Bruno Tasso; Luca Colucci-D'Amato; Elena Gatta; Michele Tonelli; Tullio Florio
Journal:  Mol Neurobiol       Date:  2014-11-18       Impact factor: 5.590

9.  Role of interleukin-1 in prion disease-associated astrocyte activation.

Authors:  Julia Schultz; Anja Schwarz; Sabine Neidhold; Michael Burwinkel; Constanze Riemer; Dietrich Simon; Manfred Kopf; Markus Otto; Michael Baier
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

10.  Distinct cell proliferation events during abstinence after alcohol dependence: microglia proliferation precedes neurogenesis.

Authors:  K Nixon; D H Kim; E N Potts; J He; F T Crews
Journal:  Neurobiol Dis       Date:  2008-05-03       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.